Skip to main content

IIan Aharoni, MD

IIan Aharoni, MD

Gastroenterologist

Digestive Health and Surgery

Ilan Aharoni

Overview

Ilan Aharoni, MD, is board certified in gastroenterology and internal medicine with a special interest in the treatment of chronic liver disease, advanced colorectal neoplasm using EMR technique and radiofrequency ablation of Barrett's esophagus. Dr. Aharoni treats all gastroenterology and hepatology conditions, including GERD, celiac disease, inflammatory bowel disease, acute and chronic pancreatitis, chronic liver disease, Hepatitis B and C, and autoimmune liver diseases. He is fluent in English, Spanish and Hebrew, and is an active member of the American College of Gastroenterology, the American Gastroenterology Association, American Society of Gastrointestinal Endoscopy and the Florida Medical Association.

Articles

Cavernous Hemangioma of the Small Bowel: A Case Report and Literature Review

CUREUS

2018

Education & Training

Education

Sackler School of Medicine, New York, NY

Residency

Maimonides Medical Center, Brooklyn, NY

Fellowship

Mount Sinai Medical Center New York, NY

Specialty

Gastroenterology

Board Certifications

American Board of Internal Medicine

Associated Clinical Trials

NCT03926130

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

Icon for trial | I6T-MC-AMAM A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

This study is currently enrolling.

The main reason for you to take part in this study is not to treat you for your condition but to help in answering the following research questions: How safe mirikizumab is and whether you might have any side effects when you t ...